Phase-3 trial

Phase-3 trial for Covaxin will be conducted on 26,000 volunteers in 25 centers…Know more

Bharat Biotech, a leading vaccine maker that is developing India’s own vaccine for coronavirus will successfully completed the interim analysis…

Read More »